4.6 Article

CUR5g, a novel autophagy inhibitor, exhibits potent synergistic anticancer effects with cisplatin against non-small-cell lung cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biology

Identification of Compound CB-2 as a Novel Late-Stage Autophagy Inhibitor Exhibits Inhibitory Potency against A549 Cells

Zhihui Liu et al.

Summary: CB-2, a novel late-stage autophagy inhibitor, exhibits strong inhibitory potency against A549 cells by blocking the fusion of autophagosomes with lysosomes. This compound induces apoptosis and necrosis in A549 cells at high doses, while impairing migrative capacity at lower doses.

LIFE-BASEL (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Cell Biology

Curcumin: A naturally occurring autophagy modulator

Abolfazl Shakeri et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Review Oncology

Targeting Autophagy in Cancer: Recent Advances and Future Directions

Ravi K. Amaravadi et al.

CANCER DISCOVERY (2019)

Article Respiratory System

Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinoma

Chengcheng Hao et al.

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2019)

Review Multidisciplinary Sciences

The biology and management of non-small cell lung cancer

Roy S. Herbst et al.

NATURE (2018)

Review Oncology

Research progress of hydroxychloroquine and autophagy inhibitors on cancer

Ting-Ting Shi et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)

Review Biochemistry & Molecular Biology

Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer

Guangbo Liu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Review Biochemistry & Molecular Biology

Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors

Cynthia I. Chude et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Review Oncology

Targeting autophagy in cancer

Jean M. Mulcahy Levy et al.

NATURE REVIEWS CANCER (2017)

Article Cell Biology

The HOPS complex mediates autophagosome-lysosome fusion through interaction with syntaxin 17

Peidu Jiang et al.

MOLECULAR BIOLOGY OF THE CELL (2014)

Article Cell Biology

Interaction of the HOPS complex with Syntaxin 17 mediates autophagosome clearance in Drosophila

Szabolcs Takats et al.

MOLECULAR BIOLOGY OF THE CELL (2014)

Review Oncology

Chloroquine and hydroxychloroquine for cancer therapy

Gwenola Manic et al.

MOLECULAR & CELLULAR ONCOLOGY (2014)

Review Biochemistry & Molecular Biology

Maturation of autophagosomes and endosomes: A key role for Rab7

Juha M. T. Hyttinen et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)

Article Cardiac & Cardiovascular Systems

Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance

Feiran Lou et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2013)

Article Cell Biology

Role for Rab7 in maturation of late autophagic vacuoles

S Jäger et al.

JOURNAL OF CELL SCIENCE (2004)